drug

KYV-101

1 story · latest Sep 24, 2026

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by Kyverna Therapeutics

Timeline

Kyverna reports one-year data for miv-cel in stiff person syndrome and myasthenia gravis

Sep 24Clinical readoutKyverna Therapeutics

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.